Political Prisoner Sues For Being Denied Hepatitis C Treatment

Political Prisoner Sues For Being Denied Hepatitis C Treatment
An amended lawsuit submitted by lawyers of African-American political prisoner Mumia Abu-Jamal alleges that Pennsylvania state prison officials neglected to treat him for Hepatitis C, leading to the development of severe, full-body rashes and open …
Read more here.

Once Disparaged, 'Me-Too' Drugs Crucial For Lower Costs Of Cholesterol
When a cure for a hepatitis C drug, Sovaldi, was launched by Gilead at a cost of $ 84,000 for a 12-week cost of therapy, payers were outraged. Typical was last year's comment by Ms. Karen Ignagni, the President of America's Health Insurance Plans, the …
Read more here.

FDA approves new treatment for chronic hepatitis C genotype 3 infections
The U.S. Food and Drug Administration today approved Daklinza (daclatasvir) for use with sofosbuvir to treat hepatitis C virus (HCV) genotype 3 infections. Daklinza is the first drug that has demonstrated safety and efficacy to treat genotype 3 HCV …
Read more here.

Tennessee Dept. of Health issues public health advisory on hepatitis C epidemic
The rate of acute Hepatitis C cases in Tennessee has more than tripled in the last seven years, and the steadily increasing number of cases may only represent “the tip of the iceberg” of the state's Hepatitis-C epidemic, according to TDH Commissioner …
Read more here.

Urban ED Screening Finds High Rates of Hepatitis C
A new study published online August 4 in the Annals of Emergency Medicine has confirmed high rates of hepatitis C infection among users of an urban emergency department (ED). Patients at high risk were not just those known to be intravenous drug users …
Read more here.

Hepatitis increasingly goes along with heroin abuse
MACHIAS, Maine – Public health agencies and drug treatment centers nationwide are scrambling to battle an explosive increase in cases of hepatitis C, a scourge they believe stems at least in part from a surge in intravenous heroin use. In response …
Read more here.

Hepatitis C: Screening, Identification, and Care
Dr Reau: We used to think that the incidence and prevalence of hepatitis C were relatively stable, with the rate of new infections decreasing significantly after screening blood products and because universal precautions lowered iatrogenic exposure …
Read more here.


Leave a Reply